Breaks Categories: News

FridayDec 07, 2018 2:18 pm

NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Reports Voting Results from Annual Meeting

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development (“R&D”) today reported the voting results from its annual general and special meeting of shareholders of the company which took place in Mississauga, Ontario on December 6, 2018. The matters up for consideration, which were detailed in the company's management information circular dated November 7, 2018, received majority votes at the meeting, thus approving all matters. Additionally, the shareholders approved the election of all the nominated directors. Detailed voting results for the meeting together, as well as a copy of each of the new share option…

Continue Reading

FridayDec 07, 2018 10:13 am

NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Announces Final Stage CBD/Propovit Throat Spray Formulation

Innovative biotechnology company Earth Science Tech (OTCQB: ETST) today announced that its new genuine CBD/Propovit throat spray formula is nearly market-ready. ETST collaborated with Bionatus in a strategic partnership to improve the product, resulting in a new strawberry-flavored formulation enriched with ETST full-spectrum cannabinoids derived from industrial hemp. “We are very excited to see this project in the final stage,” ETST CEO and Chief Science Officer Dr. Michel Aube stated in the news release. “We have developed a product that we believe will have properties not found in any other product on the market, and we thank our team and…

Continue Reading

FridayDec 07, 2018 9:50 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) CEO Reviews 2018 Revenues and Acquisition Successes on MoneyTV with Donald Baillargeon

Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally-syndicated program reviews money-focused topics and features in-depth interviews with CEOs and executives from various companies offering insights into their operations and future outlooks. SinglePoint CEO Greg Lambrecht was featured on this week’s program to discuss SING’s 2018 revenues and acquisition successes. “Some of our projections internally for 2019 could be anywhere from $3 million to $20 million,” SinglePoint CEO Greg Lambrecht stated in the interview. “So, we're on the right track. A lot of our apps that we've built are…

Continue Reading

FridayDec 07, 2018 9:29 am

NetworkNewsBreaks – American Premium Water Corp. (HIPH) Enters Partnership with Pain Management App and Platform

American Premium Water (OTC: HIPH) recently announced its entrance into a partnership with Upside Health’s product Ouchie, a pain management app and platform designed to aid the more than 120 million Americans living with chronic pain. Through various methods, such as new treatments like cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”), Ouchie intends to empower patients to address their pain management. American Premium Water’s LALPINA CBD will be offered for sale on the platform as part of the available treatments employing CBD. “I am happy to announce the start of our partnership with Ouchie. Chronic pain affects almost 1 out of every…

Continue Reading

ThursdayDec 06, 2018 2:59 pm

NetworkNewsBreaks – Altavoz Entertainment, Inc. (AVOZ) Issues Shareholder Update; Inks MOU with Nurish.Me, LLC

Altavoz Entertainment (OTC: AVOZ) this morning announced that it has inked a memorandum of understanding (“MOU”) with Nurish.Me, LLC regarding a merger of the companies. Per the terms of the merger, Altavoz will issue preferred shares to the holders of Nurish.Me’s interests. Following the conclusion of the merger, Altavoz’s current business, including its debt, will be spun out to become a private entity owned and controlled by the company’s founder, Nelson Jacobsen. The company anticipates the merger will significantly improve its balance sheet and capitalization table. In accordance with the restructuring, the Altavoz Entertainment board and CEO have resigned and…

Continue Reading

ThursdayDec 06, 2018 11:13 am

NetworkNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Pursues Licensing to Begin Substantial Cultivation Operations in Central California

Cannabis Strategic Ventures (OTC: NUGS) this morning announced its intention to pursue twenty cannabis licenses from the California Bureau of Cannabis Control that will lead to the development of a substantial 250,000 square feet of turnkey greenhouse cannabis growth operation in the central part of the state. The targeted location is equipped with critical infrastructure, including irrigation and storage facilities, that will enable Cannabis Strategic Ventures to immediately begin operations upon receipt of permitting. “This is a significant event for our Company and its investors,” Cannabis Strategic CEO Simon Yu stated in the news release.  “At approximately one quarter million…

Continue Reading

ThursdayDec 06, 2018 10:42 am

NetworkNewsBreaks – Sugarmade, Inc. (SGMD) Eyeing Opportunity Amid California’s Expected Mass ‘Green Lighting’ of Annual Cannabis Cultivation Applications

Hydroponics supply company Sugarmade (OTCQB: SGMD) today provided comments on its expected revenue growth in hydroponic related supplies amidst the rapidly-changing California cannabis cultivation licensing environment.  Sugarmade expects accelerated revenue growth as a result of the state’s projected mass "Green Lighting" of annual cultivation permits that it projects will spur purchase of cultivation supplies by large grow operations. "Our customers, especially those in Santa Barbara, Monterey and Humbolt counties, the three most prolific cultivation areas in California, are indicting to us they too are expecting the permitting process to break free shortly and they are thus informing us of their…

Continue Reading

ThursdayDec 06, 2018 10:32 am

NetworkNewsBreaks – BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Presents Initial Data from Bria-IMT Combination Study at Major Breast Cancer Conference

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company developing targeted, safe treatment options for cancer, this morning announced the presentation of initial safety data from the combination study of its lead candidate, Bria-IMT, with pembrolizumab [KEYTRUDA®; manufactured by Merck & Co., Inc. (NYSE: MRK)] and confirmation of positive proof of concept data on Bria-IMT for advanced breast cancer at the 2018 San Antonio Breast Cancer Symposium. “I am very excited about our data continuing to show robust biological activity of Bria-IMT™ in advanced breast cancer,” Dr. Bill Williams, president and CEO of BriaCell, stated in the news release.…

Continue Reading

ThursdayDec 06, 2018 10:12 am

NetworkNewsBreaks – Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Enters Strategic Partnership with Khalifa Kush Enterprises

Supreme Cannabis Company (TSX.V: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced its entry into an exclusive consulting services agreement with Khalifa Kush Enterprises Canada ULC ("KKE Canada") an affiliate of Khalifa Kush Enterprises, LLC ("KKE USA", and together with KKE Canada "KKE").  Under the agreement, KKE will provide cannabis related consulting services to Supreme, which will, in turn, be the exclusive producer of KKE branded products in Canada and, subject to approval, other international markets outside of the U.S. This will include development of a strain based on KKE's flagship "Khalifa Kush,” and development and commercialization of a product lineup…

Continue Reading

ThursdayDec 06, 2018 9:53 am

NetworkNewsBreaks – CytoDyn Inc. (CYDY) to Host Conference Call, Provide Business Update on December 12, 2018

Biotechnology company CytoDyn Inc. (OTCQB: CYDY) this morning announced that President and CEO Nader Pourhassan, Ph.D., and Chief Medical Officer Richard Pestell, M.D., Ph.D., F.A.C.P., M.B.A., will host an investment community conference call on Wednesday, December 12, at 4:00 p.m. ET. To access the call, interested parties should dial 877-407-2986 (U.S. and Canada) or 201-378-4916 (international). A live audio webcast of the call may also be accessed via CytoDyn’s corporate website at www.CytoDyn.com under the Investors section, and it will be archived for 60 days following the conclusion of the call. Web participants are encouraged to visit the website 15…

Continue Reading